
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GSKy | Frankfurt | EUR | Delayed | |
GSK | Frankfurt | EUR | Delayed | |
GSK | TradeGate | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
GSK plc reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was GBP 7,829 million compared to GBP 6,627 million a year ago. Net income was GBP 10,315 million compared to GBP 1,168 million a year ago. Basic earnings per share from continuing operations was GBP 0.188 compared to GBP 0.219 a year ago. Diluted earnings per share from continuing operations was GBP 0.186 compared to GBP 0.216 a year ago. Basic earnings per share was GBP 2.559 compared to GBP 0.292 a year ago. Diluted earnings per share was GBP 2.523 compared to GBP 0.288 a year ago.For the nine months, sales was GBP 21,948 million compared to GBP 17,620 million a year ago. Net income was GBP 12,955 million compared to GBP 3,636 million a year ago. Basic earnings per share from continuing operations was GBP 0.736 compared to GBP 0.722 a year ago. Diluted earnings per share from continuing operations was GBP 0.725 compared to GBP 0.714 a year ago. Basic earnings per share was GBP 3.22 compared to GBP 0.908 a year ago. Diluted earnings per share was GBP 3.173 compared to GBP 0.898 a year ago.
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Total Revenue | 7829 | 6929 | 7190 | |
Gross Profit | 5443 | 4784 | 4500 | |
Operating Income | 2361 | 1709 | 1708 | |
Net Income | 10315 | 838 | 1802 |
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Total Assets | 60313 | 89045 | 89689 | 79103 |
Total Liabilities | 51597 | 66405 | 67057 | 57761 |
Total Equity | 8716 | 22640 | 22632 | 21342 |
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1321 | 2542 | ||
Cash From Investing Activities | -4094 | -3593 | ||
Cash From Financing Activities | -1326 | 7973 | ||
Net Change in Cash | -4076 | 6934 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review